Eosinophilic Esophagitis Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: E15809341E72EN
Market Monitor Global

Abstracts

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

This report contains market size and forecasts of Eosinophilic Esophagitis Treatment in Global, including the following market information:

Global Eosinophilic Esophagitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Eosinophilic Esophagitis Treatment market was valued at 133.6 million in 2021 and is projected to reach US$ 189.9 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Budesonide Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Eosinophilic Esophagitis Treatment include AstraZeneca, GSK and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eosinophilic Esophagitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eosinophilic Esophagitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Eosinophilic Esophagitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Budesonide
• Fluticasone

Global Eosinophilic Esophagitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Eosinophilic Esophagitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Eosinophilic Esophagitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Eosinophilic Esophagitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Eosinophilic Esophagitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Eosinophilic Esophagitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• GSK
• Bayer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Eosinophilic Esophagitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Eosinophilic Esophagitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EOSINOPHILIC ESOPHAGITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Eosinophilic Esophagitis Treatment Market Size: 2021 VS 2028
2.2 Global Eosinophilic Esophagitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Eosinophilic Esophagitis Treatment Players in Global Market
3.2 Top Global Eosinophilic Esophagitis Treatment Companies Ranked by Revenue
3.3 Global Eosinophilic Esophagitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Eosinophilic Esophagitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Eosinophilic Esophagitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Eosinophilic Esophagitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Eosinophilic Esophagitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Eosinophilic Esophagitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Eosinophilic Esophagitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Budesonide
  4.1.3 Fluticasone
4.2 By Type - Global Eosinophilic Esophagitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Eosinophilic Esophagitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Eosinophilic Esophagitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Eosinophilic Esophagitis Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Eosinophilic Esophagitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Eosinophilic Esophagitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Eosinophilic Esophagitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Eosinophilic Esophagitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Eosinophilic Esophagitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Eosinophilic Esophagitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Eosinophilic Esophagitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Eosinophilic Esophagitis Treatment Revenue, 2017-2028
  6.3.2 US Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.3.3 Canada Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Eosinophilic Esophagitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Eosinophilic Esophagitis Treatment Revenue, 2017-2028
  6.4.2 Germany Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.3 France Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.5 Italy Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.6 Russia Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Eosinophilic Esophagitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Eosinophilic Esophagitis Treatment Revenue, 2017-2028
  6.5.2 China Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.5.3 Japan Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.5.6 India Eosinophilic Esophagitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Eosinophilic Esophagitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Eosinophilic Esophagitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Eosinophilic Esophagitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.7.3 Israel Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Eosinophilic Esophagitis Treatment Market Size, 2017-2028
  6.7.5 UAE Eosinophilic Esophagitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Eosinophilic Esophagitis Treatment Major Product Offerings
  7.1.4 AstraZeneca Eosinophilic Esophagitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 GSK
  7.2.1 GSK Corporate Summary
  7.2.2 GSK Business Overview
  7.2.3 GSK Eosinophilic Esophagitis Treatment Major Product Offerings
  7.2.4 GSK Eosinophilic Esophagitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 GSK Key News
7.3 Bayer
  7.3.1 Bayer Corporate Summary
  7.3.2 Bayer Business Overview
  7.3.3 Bayer Eosinophilic Esophagitis Treatment Major Product Offerings
  7.3.4 Bayer Eosinophilic Esophagitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bayer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Eosinophilic Esophagitis Treatment Market Opportunities & Trends in Global Market
Table 2. Eosinophilic Esophagitis Treatment Market Drivers in Global Market
Table 3. Eosinophilic Esophagitis Treatment Market Restraints in Global Market
Table 4. Key Players of Eosinophilic Esophagitis Treatment in Global Market
Table 5. Top Eosinophilic Esophagitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Eosinophilic Esophagitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Eosinophilic Esophagitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Eosinophilic Esophagitis Treatment Product Type
Table 9. List of Global Tier 1 Eosinophilic Esophagitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eosinophilic Esophagitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Eosinophilic Esophagitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Eosinophilic Esophagitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Eosinophilic Esophagitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Eosinophilic Esophagitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Eosinophilic Esophagitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Eosinophilic Esophagitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Eosinophilic Esophagitis Treatment Product Offerings
Table 32. AstraZeneca Eosinophilic Esophagitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Eosinophilic Esophagitis Treatment Product Offerings
Table 35. GSK Eosinophilic Esophagitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Eosinophilic Esophagitis Treatment Product Offerings
Table 38. Bayer Eosinophilic Esophagitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Eosinophilic Esophagitis Treatment Segment by Type in 2021
Figure 2. Eosinophilic Esophagitis Treatment Segment by Application in 2021
Figure 3. Global Eosinophilic Esophagitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eosinophilic Esophagitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eosinophilic Esophagitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eosinophilic Esophagitis Treatment Revenue in 2021
Figure 8. By Type - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Eosinophilic Esophagitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Eosinophilic Esophagitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Eosinophilic Esophagitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Eosinophilic Esophagitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Eosinophilic Esophagitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)